Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Graziano

Showing results (61-70 of 165) with videos related to

Pageof 17
Sort By:
Clinical and Experimental Rheumatology|May 26, 1999
Severe cold agglutinin disease and cryoglobulinemia secondary to a monoclonal anti-Pr2 IgM lambda cryoagglutininJ Z Ciejka, E B Cook, D Lawler, et al.
Journal of the National Cancer Institute|March 1, 1984
Monoclonal antibodies reactive with small cell carcinoma of the lungE D Ball, R F Graziano, O S Pettengill, et al.
Anti-Cancer Drugs|June 23, 1998
Phase II study of paclitaxel in pretreated advanced gastric cancerS Cascinu, F Graziano, N Cardarelli, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 4, 2015
Probing the factor structure of metabolic syndrome in Sardinian genetic isolatesF Graziano, M Grassi, S Sacco, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1989
Monoclonal antibodies that bind to distinct epitopes on Fc gamma RI are able to trigger receptor functionP M Guyre, R F Graziano, B A Vance, et al.
British Journal of Neurosurgery|March 12, 2019
Pulsed radiofrequency energy device (PEAK plasmablade™) and CustomBone<sup>®</sup> Cranioplasty: an appealing surgical rendez-vousF Graziano, R Maugeri, G R Giammalva, et al.
Cancer|December 24, 1997
A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responsesD Tummarello, D Mari, F Graziano, et al.
Cancer|June 1, 1996
Consolidation biochemotherapy for patients with advanced nonsmall cell lung carcinoma responding to induction PVM (cisplatin, vinblastine, mitomycin-C) regimen. A phase II studyD Tummarello, F Graziano, P Isidori, et al.
Anticancer Research|September 1, 1994
Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapyD Tummarello, F Graziano, D Mari, et al.
Chirurgia Italiana|June 9, 2001
[Experience of 10 years with the surgical treatment of lung cancer in elderly patients]M Filippetti, G Crucitti, C Andreetti, et al.
Pageof 17

Showing results (61-70 of 165) with videos related to

Sort By:
Pageof 17
Clinical and Experimental Rheumatology|May 26, 1999
Severe cold agglutinin disease and cryoglobulinemia secondary to a monoclonal anti-Pr2 IgM lambda cryoagglutininJ Z Ciejka, E B Cook, D Lawler, et al.
Journal of the National Cancer Institute|March 1, 1984
Monoclonal antibodies reactive with small cell carcinoma of the lungE D Ball, R F Graziano, O S Pettengill, et al.
Anti-Cancer Drugs|June 23, 1998
Phase II study of paclitaxel in pretreated advanced gastric cancerS Cascinu, F Graziano, N Cardarelli, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 4, 2015
Probing the factor structure of metabolic syndrome in Sardinian genetic isolatesF Graziano, M Grassi, S Sacco, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1989
Monoclonal antibodies that bind to distinct epitopes on Fc gamma RI are able to trigger receptor functionP M Guyre, R F Graziano, B A Vance, et al.
British Journal of Neurosurgery|March 12, 2019
Pulsed radiofrequency energy device (PEAK plasmablade™) and CustomBone<sup>®</sup> Cranioplasty: an appealing surgical rendez-vousF Graziano, R Maugeri, G R Giammalva, et al.
Cancer|December 24, 1997
A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responsesD Tummarello, D Mari, F Graziano, et al.
Cancer|June 1, 1996
Consolidation biochemotherapy for patients with advanced nonsmall cell lung carcinoma responding to induction PVM (cisplatin, vinblastine, mitomycin-C) regimen. A phase II studyD Tummarello, F Graziano, P Isidori, et al.
Anticancer Research|September 1, 1994
Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapyD Tummarello, F Graziano, D Mari, et al.
Chirurgia Italiana|June 9, 2001
[Experience of 10 years with the surgical treatment of lung cancer in elderly patients]M Filippetti, G Crucitti, C Andreetti, et al.
Pageof 17